Skip to main content
Livermore
Livermore
ZHEN

Simplex Trading, LLC

SEC CIK
0001488542
Latest filing
Aug 12, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by Simplex Trading, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2026)
14,357
Value
$1.00M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of NKTR by Simplex Trading, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,357$1.00M<0.1%+8,635+150.9%AddedHolders
Q1 20265,722$411.7K<0.1%−16,214−73.9%ReducedHolders
Q4 202521,936$927.5K<0.1%−54,514−71.3%ReducedHolders
Q3 202576,450$4.35M0.1%+29,497+62.8%AddedHolders
Q2 202546,953$1.21M<0.1%+24,024+104.8%AddedConverted for a 1-for-15 splitHolders
Q1 2025343,935$233.0K<0.1%+331,258+2,613.1%AddedHolders
Q4 202412,677$11.0K<0.1%+5,689+81.4%AddedHolders
Q3 20246,988$9.00K<0.1%+4,737+210.4%AddedHolders
Q2 20242,251$2.00K<0.1%+2,251NewHolders
Q1 20240$00.0%−3,819−100.0%Sold outHolders
Q4 20233,819$2.00K<0.1%−6,806−64.1%ReducedHolders
Q3 202310,625$6.00K<0.1%+3,515+49.4%AddedHolders
Q2 20237,110$4.00K<0.1%+2,149+43.3%AddedHolders
Q1 20234,961$3.00K<0.1%−1,162−19.0%ReducedHolders
Q4 20226,123$13.0K<0.1%−13,181−68.3%ReducedHolders
Q3 202219,304$61.0K<0.1%+4,608+31.4%AddedHolders
Q2 202214,696$55.0K<0.1%−4,204−22.2%ReducedHolders
Q1 202218,900$101.0K<0.1%+18,900NewHolders
Q4 20210$00.0%−5,743−100.0%Sold outHolders
Q3 20215,743$100.0K<0.1%−800−12.2%ReducedHolders
Q2 20216,543$112.0K<0.1%+836+14.6%AddedHolders
Q1 20215,707$114.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.